MARSHALL WACE, LLP - LUMIRADX LTD ownership

Back to all holdings Add to watchlist

LUMIRADX LTD's ticker is and the CUSIP is G5709L117. A total of 20 filers reported holding LUMIRADX LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Links

Filings

Quarter-by-quarter ownership

MARSHALL WACE, LLP ownership history of LUMIRADX LTD
	Value		Shares		Weighting
Q3 2022	$172,000	-72.3%	168,400	-27.7%	0.00%	-100.0%
Q2 2022	$621,000	-59.2%	232,867	-8.1%	0.00%	-66.7%
Q1 2022	$1,522,000	-32.5%	253,426	0.0%	0.00%	-25.0%
Q4 2021	$2,254,000	+7.5%	253,426	0.0%	0.00%	-55.6%
Q3 2021	$2,096,000	–	253,426	–	0.01%	–
Download

Other shareholders

LUMIRADX LTD shareholders Q4 2022
Name	Shares	Value	Weighting ↓
CVS HEALTH Corp	5,352,106	$1,268,984	0.68%
Covalent Partners LLC	27,500	$993	0.00%
Senvest Management, LLC	2,070,786	$60,053	0.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC.	0	$0	0.00%
MMCAP International Inc. SPC	42,976	$1,246	0.00%
CITIGROUP INC	20,058	$724	0.00%
MORGAN STANLEY	3,727	$108	0.00%
Walleye Trading LLC	20,000	$580	0.00%
Walleye Capital LLC	30,000	$870	0.00%
Ancora Advisors LLC	15,470	$558	0.00%

View complete list of LUMIRADX LTD shareholders